Rephonic
Artwork for Treating Blood Cancers

Treating Blood Cancers

Blood Cancer United
Multiple Myeloma
Bispecific Antibodies
Clinical Trials
CAR T-Cell Therapy
Hodgkin Lymphoma
Myeloma
Cancer Treatment
Measurable Residual Disease
CD20
Lymphoma
Chronic Lymphocytic Leukemia
Chemotherapy
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Pediatric Blood Cancers
Nivolumab
Pembrolizumab
Brentuximab Vedotin
Radiation
Leukemia and Lymphoma Society

Podcast series for professionals by Blood Cancer United

PublishesTwice monthlyEpisodes120Founded8 years ago
Number of ListenersCategories
MedicineEducationHealth & Fitness

Listen to this Podcast

Artwork for Treating Blood Cancers

Latest Episodes

Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Recorded on June 2, 2026

Marina Kremyanskaya, MD, PhD

Associate Professor

Tisch Cancer Institute

Icahn School of Medicine at Mount Sinai

New York, NY

J... more

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Recorded on May 28, 2026

Tara Gregory, MD

President

Colorado Blood Cancer Institute

Denver, CO

Jay Spieg... more

Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA

Recorded on May 12, 2026

Lori Muffly, MD, MS

Professor of Medicine

Division of Blood and Marrow Transplantation & Cellular Therapy

Stanford Medicine

Stanford, CA

In this episode, Dr.... more

Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Recorded on April 23, 2026

Mayra Allen, PhD

Clinical Psychologist, Psycho-Oncology Service

UCSF Helen Diller Family Comprehensive Cancer Center

San Fr... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Blood Cancer Talks
Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
The ONS Podcast
The ONS PodcastOncology Nursing Society
Blood Podcast
Blood PodcastAmerican Society of Hematology

Recent Guests

Dr. Marina Kremyanskaya
Associate professor of medicine, hematology, and medical oncology; medical director of inpatient oncology
Icahn School of Medicine at Mount Sinai; Mount Sinai Hospital, New York
Episode: Mastocytosis: What Clinicians Need to Know
Dr. Tara Gregory
President of the Colorado Blood Cancer Institute in Denver; Plasma Cell Disease Group member; unrelated donor program director
Colorado Blood Cancer Institute
Episode: CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Dr. Jay Spiegel
Assistant Professor in the Division of Transplant and Cellular Therapy
Sylvester Comprehensive Cancer Center, University of Miami
Episode: CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Dr. Lori Muffly
Professor of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Medicine
Stanford Medicine
Episode: Optimizing HSCT in Blood Cancers
Dr. Mayra Allen
Clinical psychologist in the Psycho-Oncology Service
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Episode: Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Dr. David Sallman
Associate member, Department of Malignant Hematology, Moffitt Cancer Center
Moffitt Cancer Center
Episode: Driving Progress in AML
Matthew Loscalzo
Licensed clinical social worker, APOS fellow, professor emeritus; founding director of supportive care programs
City of Hope National Medical Center; American Psycho-Oncology Society
Episode: Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Dr. Peter Voorhees
Director of Outreach for Hematologic Malignancies, Plasma Cell Disorder Program
Levine Cancer Center, Wake Forest University School of Medicine
Episode: Optimizing Outcomes in Myeloma
Amy Pierre
Senior Clinical Director in Research Oncology
Flatiron Health; Nurse Practitioner at Memorial Sloan Kettering Cancer Center
Episode: Optimizing Outcomes in Myeloma

Host

Dr. Ken Miller
Host of Treating Blood Cancers; medical oncologist/hematologist; Blood Cancer United volunteer

Reviews

4.7 out of 5 stars from 27 ratings
  • Lymphoma lesbian thanks you!

    This was very comforting and informative. Wyoming isn’t the easiest place to get sensitive LGBTQI care. But we are doing ok so far. Blessings on your important work.

    Apple Podcasts
    5
    Ms.Vader
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Content covers equity and access, which resonates with care teams and advocates.
Guests bring deep expertise and clear clinical takeaways.
The show is praised for bridging academic insights with real-world patient experiences.
Listeners appreciate the practical resources for clinicians and families.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Mastocytosis: What Clinicians Need to Know
Q: Can you share a patient case that illustrates the impact of these therapies?
A long-term patient with systemic mastocytosis showed dramatic allele burden reduction, decreased organomegaly, and normalization of tryptase after starting a KIT inhibitor, highlighting how targeted therapy can transform disease course and quality of life.
Mastocytosis: What Clinicians Need to Know
Q: What are the key treatment options for advanced systemic mastocytosis and how have they evolved?
Treatment has moved from nonspecific therapies like steroids to targeted KIT inhibitors, with mitostorin and then avapritinib providing disease control, reduction in mitotic burden, and improved organ and blood parameters; newer KIT inhibitors are being developed to enhance efficacy and tolerability.
Mastocytosis: What Clinicians Need to Know
Q: Could you summarize how systemic mastocytosis is diagnosed and what criteria clinicians use?
Diagnosis hinges on a major criterion—mast cell accumulation in bone marrow or other tissues—and a combination of minor criteria (such as abnormal mast cell markers and elevated tryptase). One major plus either one minor or three minors confirms systemic mastocytosis.
CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Q: What is CAR-T? And what are the predictors for success or failure?
CAR-T involves harvesting a patient's T cells, reprogramming them to express a tumor-targeting receptor, and re-infusing them to attack cancer, with success linked to factors like disease burden, immune fitness, and timing relative to other therapies; high disease burden can increase toxicity, while better T-cell fitness and MRD-negative status tend to predict more favorable outcomes.
Strategies and Advances in AML
Q: Could you share a couple of trials or developments you're excited about, and how they might change patient outcomes in the near term?
Menin inhibitors and other targeted therapies show promise, with expanding trials in newly diagnosed AML and efforts to optimize dosing and sequencing; BEAT-AML and OPTI-AML exemplify patient-centered trial design.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Treating Blood Cancers

What is Treating Blood Cancers about and what kind of topics does it cover?

This program centers on hematology and oncology for professionals, with a steady focus on hematopoietic stem cell transplantation, targeted therapies, and survivorship across blood cancers. Recent episodes cover advances in AML, CLL, myeloma, and hairy cell leukemia, along with practical topics like expanded access, fertility preservation, burnout in healthcare teams, and equitable cancer care. A standout pattern is a strong emphasis on real-world practice, multidisciplinary collaboration, and patient- and caregiver-facing resources, often bridging academic insights with community care and policy considerations. Noteworthy is ongoing coverage of CAR-T and bispecific therapies, MRD-driven treatment decisions, and the PEDAL pediatric trials e... more

Where can I find podcast stats for Treating Blood Cancers?

Rephonic provides a wide range of podcast stats for Treating Blood Cancers. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Treating Blood Cancers and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Treating Blood Cancers get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Treating Blood Cancers, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Treating Blood Cancers?

Rephonic provides comprehensive predictive audience data for Treating Blood Cancers, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Treating Blood Cancers have?

To see how many followers or subscribers Treating Blood Cancers has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Treating Blood Cancers?

These podcasts share a similar audience with Treating Blood Cancers:

1. Two Onc Docs
2. Blood Cancer Talks
3. The ONS Podcast
4. The Bloodline with Blood Cancer United Podcast
5. Blood Podcast

How many episodes of Treating Blood Cancers are there?

Treating Blood Cancers launched 8 years ago and published 120 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Treating Blood Cancers?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Treating Blood Cancers?

Rephonic pulls ratings and reviews for Treating Blood Cancers from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Treating Blood Cancers?

Rephonic provides full transcripts for episodes of Treating Blood Cancers. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Treating Blood Cancers?

Recent guests on Treating Blood Cancers include:

1. Dr. Marina Kremyanskaya
2. Dr. Tara Gregory
3. Dr. Jay Spiegel
4. Dr. Lori Muffly
5. Dr. Mayra Allen
6. Dr. David Sallman
7. Matthew Loscalzo
8. Dr. Peter Voorhees

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days